The Cell Dissociation Market is expected to register a CAGR of 15.2% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Cell Dissociation Market report covers analysis By Product, Type, Tissue Type, and End User. The global analysis is further broken down at the regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Cell Dissociation Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Cell Dissociation Market Segmentation
Product- Enzymatic Dissociation Products
- Instruments and Accessories
- Non-Enzymatic Dissociation Products;
- Non-Enzymatic Dissociation Products
- Tissue Dissociation
- Epithelial Tissue
- Connective Tissue
- Other Tissues
- Research and Academic Institutes
- Pharmaceutical and Biotechnology Companies
- Other End Users
Strategic Insights
Cell Dissociation Market Growth Drivers- Recombinant Therapies Derived from Mammalian Cells: There is a noticeable growth of recombinant therapies derived from mammalian cells. The percentage of recombinant therapies derived from mammalian cells has increased significantly in the sector of biopharmaceutical drugs since 2002- number of approved recombinant goods, derived from mammalian cell culture increased. the total number of recombinant goods developed by mammalian cell cultureware passed 300 in June 2022. This shows a rapid transition to treatments, based on mammals. This rapid transition to mammalian-based treatments explains the percentage of mammal-based treatments, which will represent around 67, in 2022. The component of cell culture goods, such as cell dissociation, necessary for having recombinant therapies, based on mammals, explains the development of the sector.
- Biopharma R&D Spending Driving Growth: One of the drivers for this growth in the market was an expansion in R&D spending at biopharma. In 2022, European pharmaceutical companies spent EUR 47.01 billion (USD 49.43 billion), and the 2024 report of the European Federation of Pharmaceutical Industries and Associations projected that in 2023 it would reach EUR 50 billion (USD 54.11 billion). Several companies are investing in biopharmaceutical R and D. In September 2022, the Biomedical Advanced Research and Development Authority (BARDA) gave Marinus Pharmaceuticals a large contract option for about USD 12.3 million to increase ganaxolone manufacturing.
- Biotechnology and Pharmaceutical Industries Contribute to Market Growth: Growth of the biotechnology and pharmaceutical industries contributes to the growth of the cell dissociation market. Reports from the market indicate that these industries are dependent upon effective cell dissociation to realize clinical drugs and other tissue engineering applications. The strong growth of biologics and biosimilars is driving this market forward. Many large investments are resulting from the trend to focus on biologics for drug discovery studies and therapy development, notably interferons, growth factors, and monoclonal antibodies. This has increased market competition and will thus increase the market share for established advanced dissociation products in the forecast period in various regions worldwide.
- Cell Dissociation Products in High Demand: The cell dissociation product market is growing because the activities of biopharmaceutical companies have increased and more of them are dedicating their RD to developing novel drugs. Biopharmaceuticals demand has been skyrocketing, leading to the development of a new business model called the ‘contract development manufacturing organization (CDMO)’, which is meant to accelerate biopharmaceutical design and manufacturing, as described in this March 2022 article published on PubMed.CDMOs are perfectly adapting to this increase in pharmaceutical industry expectations, and are poised to handle higher bite-volume production, because of growing R&D efforts by pharma and biopharma companies targeting cell-related medicines, which further strengthens market growth.
- Competition for Product Dominance in the Market: The rise of personalized medicine, which has applications in the domains of oncology and immunotherapy, means that precision cell-dissociation tools are in demand. PEST analysis shows that there is a strong supportive regulatory force for the use of patient-individualized treatments. The dynamics of the market reveal the fact that 20 percent of dissociation techniques have application in patient-specific research and that the product required by this application will be highly specific. Thus, major players in the market have been modifying their strategies, focusing on R&D, to develop products that are suitable for the application of patient-specific therapies.
- Non-Cytotoxic Dissociation Products Gaining Popularity: On the other side, the companies are competing with each other for their product dominance in the market, with revolutionary and proactive products with more end-user applications and more revenue. Likewise, most of the R&D researchers in research institutes, biotechnology companies, and clinics for transplantation have been using traditional enzymatic dissociation products for isolating and dissociating cells from primary tissues. While these enzymatic dissociation products have the advantage of better dissociation during research, they can inherently be cytotoxic thus damaging the viable cells. Several companies are competing with each other with new offerings in non-enzymatic but non-cytotoxic products. Cells can be easily dissociated after treatment with this product. The cell dissociation offered by this product is non-cytotoxic on vital cells and hence causes no damage to the cells that are required for different applications.
- Cell-Based Assays Increasing Demand for Dissociation Reagents: Cell-dissociation reagents are in great demand as innovative and efficient cell-based assays for drug discovery, toxicological screening, and diagnostic applications are being employed worldwide, increasing the demand for dissociation products. Almost 30 percent of laboratories in North America use cell-based assays, providing significant opportunities for dissociation reagent manufacturers.
- Innovative and Sophisticated Assays: According to competitive analysis in the dissociation reagent market, there has been a trend in the last few years to adopt innovative and sophisticated assays, providing industry players with an opportunity to market tailored dissociation solutions with a better track record for cell viability and integrity.
- Immunology Research Propelling Cell Dissociation Demand: The increasing demand for cell dissociation in immunology research, especially in North America, is a major propellant for this market, as more than 35 percent of research worldwide is centered on the assessment, characteristics, and behavior of immune cells. This demand opens competitive space for manufacturers providing dissociation enzymes highly specific to immune cells. Given the growing competitive analysis of the immunology space, companies with advanced dissociation reagents can expect an expanding market share
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Cell Dissociation Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Cell Dissociation Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Key companies in this market are: VitaCyte, LLC., BD, Thermo Fisher Scientific Inc., PAN-Biotech, Merck KGaA, HiMedia Laboratories, Miltenyi Biotec GmbH, STEMCELL Technologies Inc., General Electric Company, ATCC
Key future trends in this market are - Advancements in stem cell research, Growth in cell therapy applications, Increase in tissue culture studies
The Cell Dissociation Market is expected to register a CAGR of 15.2% from 2023-2031.
The major factors impacting the Cell Dissociation Market are: Advancements in Cell-Based Research, Increasing Demand for Personalized Medicine, and Growth in Biotechnology and Pharmaceutical Industries
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cell Dissociation Market - By Product
1.3.2 Cell Dissociation Market - By Type
1.3.3 Cell Dissociation Market - By Tissue Type
1.3.4 Cell Dissociation Market - By End User
1.3.5 Cell Dissociation Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CELL DISSOCIATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CELL DISSOCIATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CELL DISSOCIATION MARKET - GLOBAL MARKET ANALYSIS
6.1. CELL DISSOCIATION - GLOBAL MARKET OVERVIEW
6.2. CELL DISSOCIATION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. CELL DISSOCIATION MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ENZYMATIC DISSOCIATION PRODUCTS
7.3.1. Overview
7.3.2. Enzymatic Dissociation Products Market Forecast and Analysis
7.3.3. Papain Market
7.3.3.1. Overview
7.3.3.2. Papain Market Forecast and Analysis
7.3.4. Elastase Market
7.3.4.1. Overview
7.3.4.2. Elastase Market Forecast and Analysis
7.3.5. Collagenase Market
7.3.5.1. Overview
7.3.5.2. Collagenase Market Forecast and Analysis
7.3.6. Trypsin Market
7.3.6.1. Overview
7.3.6.2. Trypsin Market Forecast and Analysis
7.3.7. Hyaluronidase Market
7.3.7.1. Overview
7.3.7.2. Hyaluronidase Market Forecast and Analysis
7.3.8. DNAse Market
7.3.8.1. Overview
7.3.8.2. DNAse Market Forecast and Analysis
7.3.9. Other Enzymes Market
7.3.9.1. Overview
7.3.9.2. Other Enzymes Market Forecast and Analysis
7.4. INSTRUMENTS AND ACCESSORIES
7.4.1. Overview
7.4.2. Instruments and Accessories Market Forecast and Analysis
7.5. NON-ENZYMATIC DISSOCIATION PRODUCTS
7.5.1. Overview
7.5.2. Non-Enzymatic Dissociation Products Market Forecast and Analysis
8. CELL DISSOCIATION MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. NON-ENZYMATIC DISSOCIATION PRODUCTS
8.3.1. Overview
8.3.2. Non-Enzymatic Dissociation Products Market Forecast and Analysis
8.4. TISSUE DISSOCIATION
8.4.1. Overview
8.4.2. Tissue Dissociation Market Forecast and Analysis
9. CELL DISSOCIATION MARKET - REVENUE AND FORECASTS TO 2028 - TISSUE TYPE
9.1. OVERVIEW
9.2. TISSUE TYPE MARKET FORECASTS AND ANALYSIS
9.3. EPITHELIAL TISSUE
9.3.1. Overview
9.3.2. Epithelial Tissue Market Forecast and Analysis
9.4. CONNECTIVE TISSUE
9.4.1. Overview
9.4.2. Connective Tissue Market Forecast and Analysis
9.5. OTHER TISSUES
9.5.1. Overview
9.5.2. Other Tissues Market Forecast and Analysis
10. CELL DISSOCIATION MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. RESEARCH AND ACADEMIC INSTITUTES
10.3.1. Overview
10.3.2. Research and Academic Institutes Market Forecast and Analysis
10.4. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.4.1. Overview
10.4.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
10.5. OTHER END USERS
10.5.1. Overview
10.5.2. Other End Users Market Forecast and Analysis
11. CELL DISSOCIATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Cell Dissociation Market Overview
11.1.2 North America Cell Dissociation Market Forecasts and Analysis
11.1.3 North America Cell Dissociation Market Forecasts and Analysis - By Product
11.1.4 North America Cell Dissociation Market Forecasts and Analysis - By Type
11.1.5 North America Cell Dissociation Market Forecasts and Analysis - By Tissue Type
11.1.6 North America Cell Dissociation Market Forecasts and Analysis - By End User
11.1.7 North America Cell Dissociation Market Forecasts and Analysis - By Countries
11.1.7.1 United States Cell Dissociation Market
11.1.7.1.1 United States Cell Dissociation Market by Product
11.1.7.1.2 United States Cell Dissociation Market by Type
11.1.7.1.3 United States Cell Dissociation Market by Tissue Type
11.1.7.1.4 United States Cell Dissociation Market by End User
11.1.7.2 Canada Cell Dissociation Market
11.1.7.2.1 Canada Cell Dissociation Market by Product
11.1.7.2.2 Canada Cell Dissociation Market by Type
11.1.7.2.3 Canada Cell Dissociation Market by Tissue Type
11.1.7.2.4 Canada Cell Dissociation Market by End User
11.1.7.3 Mexico Cell Dissociation Market
11.1.7.3.1 Mexico Cell Dissociation Market by Product
11.1.7.3.2 Mexico Cell Dissociation Market by Type
11.1.7.3.3 Mexico Cell Dissociation Market by Tissue Type
11.1.7.3.4 Mexico Cell Dissociation Market by End User
11.2. EUROPE
11.2.1 Europe Cell Dissociation Market Overview
11.2.2 Europe Cell Dissociation Market Forecasts and Analysis
11.2.3 Europe Cell Dissociation Market Forecasts and Analysis - By Product
11.2.4 Europe Cell Dissociation Market Forecasts and Analysis - By Type
11.2.5 Europe Cell Dissociation Market Forecasts and Analysis - By Tissue Type
11.2.6 Europe Cell Dissociation Market Forecasts and Analysis - By End User
11.2.7 Europe Cell Dissociation Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Cell Dissociation Market
11.2.7.1.1 Germany Cell Dissociation Market by Product
11.2.7.1.2 Germany Cell Dissociation Market by Type
11.2.7.1.3 Germany Cell Dissociation Market by Tissue Type
11.2.7.1.4 Germany Cell Dissociation Market by End User
11.2.7.2 France Cell Dissociation Market
11.2.7.2.1 France Cell Dissociation Market by Product
11.2.7.2.2 France Cell Dissociation Market by Type
11.2.7.2.3 France Cell Dissociation Market by Tissue Type
11.2.7.2.4 France Cell Dissociation Market by End User
11.2.7.3 Italy Cell Dissociation Market
11.2.7.3.1 Italy Cell Dissociation Market by Product
11.2.7.3.2 Italy Cell Dissociation Market by Type
11.2.7.3.3 Italy Cell Dissociation Market by Tissue Type
11.2.7.3.4 Italy Cell Dissociation Market by End User
11.2.7.4 Spain Cell Dissociation Market
11.2.7.4.1 Spain Cell Dissociation Market by Product
11.2.7.4.2 Spain Cell Dissociation Market by Type
11.2.7.4.3 Spain Cell Dissociation Market by Tissue Type
11.2.7.4.4 Spain Cell Dissociation Market by End User
11.2.7.5 United Kingdom Cell Dissociation Market
11.2.7.5.1 United Kingdom Cell Dissociation Market by Product
11.2.7.5.2 United Kingdom Cell Dissociation Market by Type
11.2.7.5.3 United Kingdom Cell Dissociation Market by Tissue Type
11.2.7.5.4 United Kingdom Cell Dissociation Market by End User
11.2.7.6 Rest of Europe Cell Dissociation Market
11.2.7.6.1 Rest of Europe Cell Dissociation Market by Product
11.2.7.6.2 Rest of Europe Cell Dissociation Market by Type
11.2.7.6.3 Rest of Europe Cell Dissociation Market by Tissue Type
11.2.7.6.4 Rest of Europe Cell Dissociation Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Cell Dissociation Market Overview
11.3.2 Asia-Pacific Cell Dissociation Market Forecasts and Analysis
11.3.3 Asia-Pacific Cell Dissociation Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Cell Dissociation Market Forecasts and Analysis - By Type
11.3.5 Asia-Pacific Cell Dissociation Market Forecasts and Analysis - By Tissue Type
11.3.6 Asia-Pacific Cell Dissociation Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Cell Dissociation Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Cell Dissociation Market
11.3.7.1.1 Australia Cell Dissociation Market by Product
11.3.7.1.2 Australia Cell Dissociation Market by Type
11.3.7.1.3 Australia Cell Dissociation Market by Tissue Type
11.3.7.1.4 Australia Cell Dissociation Market by End User
11.3.7.2 China Cell Dissociation Market
11.3.7.2.1 China Cell Dissociation Market by Product
11.3.7.2.2 China Cell Dissociation Market by Type
11.3.7.2.3 China Cell Dissociation Market by Tissue Type
11.3.7.2.4 China Cell Dissociation Market by End User
11.3.7.3 India Cell Dissociation Market
11.3.7.3.1 India Cell Dissociation Market by Product
11.3.7.3.2 India Cell Dissociation Market by Type
11.3.7.3.3 India Cell Dissociation Market by Tissue Type
11.3.7.3.4 India Cell Dissociation Market by End User
11.3.7.4 Japan Cell Dissociation Market
11.3.7.4.1 Japan Cell Dissociation Market by Product
11.3.7.4.2 Japan Cell Dissociation Market by Type
11.3.7.4.3 Japan Cell Dissociation Market by Tissue Type
11.3.7.4.4 Japan Cell Dissociation Market by End User
11.3.7.5 South Korea Cell Dissociation Market
11.3.7.5.1 South Korea Cell Dissociation Market by Product
11.3.7.5.2 South Korea Cell Dissociation Market by Type
11.3.7.5.3 South Korea Cell Dissociation Market by Tissue Type
11.3.7.5.4 South Korea Cell Dissociation Market by End User
11.3.7.6 Rest of Asia-Pacific Cell Dissociation Market
11.3.7.6.1 Rest of Asia-Pacific Cell Dissociation Market by Product
11.3.7.6.2 Rest of Asia-Pacific Cell Dissociation Market by Type
11.3.7.6.3 Rest of Asia-Pacific Cell Dissociation Market by Tissue Type
11.3.7.6.4 Rest of Asia-Pacific Cell Dissociation Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Cell Dissociation Market Overview
11.4.2 Middle East and Africa Cell Dissociation Market Forecasts and Analysis
11.4.3 Middle East and Africa Cell Dissociation Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Cell Dissociation Market Forecasts and Analysis - By Type
11.4.5 Middle East and Africa Cell Dissociation Market Forecasts and Analysis - By Tissue Type
11.4.6 Middle East and Africa Cell Dissociation Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Cell Dissociation Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Cell Dissociation Market
11.4.7.1.1 South Africa Cell Dissociation Market by Product
11.4.7.1.2 South Africa Cell Dissociation Market by Type
11.4.7.1.3 South Africa Cell Dissociation Market by Tissue Type
11.4.7.1.4 South Africa Cell Dissociation Market by End User
11.4.7.2 Saudi Arabia Cell Dissociation Market
11.4.7.2.1 Saudi Arabia Cell Dissociation Market by Product
11.4.7.2.2 Saudi Arabia Cell Dissociation Market by Type
11.4.7.2.3 Saudi Arabia Cell Dissociation Market by Tissue Type
11.4.7.2.4 Saudi Arabia Cell Dissociation Market by End User
11.4.7.3 U.A.E Cell Dissociation Market
11.4.7.3.1 U.A.E Cell Dissociation Market by Product
11.4.7.3.2 U.A.E Cell Dissociation Market by Type
11.4.7.3.3 U.A.E Cell Dissociation Market by Tissue Type
11.4.7.3.4 U.A.E Cell Dissociation Market by End User
11.4.7.4 Rest of Middle East and Africa Cell Dissociation Market
11.4.7.4.1 Rest of Middle East and Africa Cell Dissociation Market by Product
11.4.7.4.2 Rest of Middle East and Africa Cell Dissociation Market by Type
11.4.7.4.3 Rest of Middle East and Africa Cell Dissociation Market by Tissue Type
11.4.7.4.4 Rest of Middle East and Africa Cell Dissociation Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Cell Dissociation Market Overview
11.5.2 South and Central America Cell Dissociation Market Forecasts and Analysis
11.5.3 South and Central America Cell Dissociation Market Forecasts and Analysis - By Product
11.5.4 South and Central America Cell Dissociation Market Forecasts and Analysis - By Type
11.5.5 South and Central America Cell Dissociation Market Forecasts and Analysis - By Tissue Type
11.5.6 South and Central America Cell Dissociation Market Forecasts and Analysis - By End User
11.5.7 South and Central America Cell Dissociation Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Cell Dissociation Market
11.5.7.1.1 Brazil Cell Dissociation Market by Product
11.5.7.1.2 Brazil Cell Dissociation Market by Type
11.5.7.1.3 Brazil Cell Dissociation Market by Tissue Type
11.5.7.1.4 Brazil Cell Dissociation Market by End User
11.5.7.2 Argentina Cell Dissociation Market
11.5.7.2.1 Argentina Cell Dissociation Market by Product
11.5.7.2.2 Argentina Cell Dissociation Market by Type
11.5.7.2.3 Argentina Cell Dissociation Market by Tissue Type
11.5.7.2.4 Argentina Cell Dissociation Market by End User
11.5.7.3 Rest of South and Central America Cell Dissociation Market
11.5.7.3.1 Rest of South and Central America Cell Dissociation Market by Product
11.5.7.3.2 Rest of South and Central America Cell Dissociation Market by Type
11.5.7.3.3 Rest of South and Central America Cell Dissociation Market by Tissue Type
11.5.7.3.4 Rest of South and Central America Cell Dissociation Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CELL DISSOCIATION MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. CELL DISSOCIATION MARKET, KEY COMPANY PROFILES
14.1. VITACYTE, LLC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. BD
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. THERMO FISHER SCIENTIFIC INC.
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. PAN-BIOTECH
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. MERCK KGAA
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. HIMEDIA LABORATORIES
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. MILTENYI BIOTEC GMBH
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. STEMCELL TECHNOLOGIES INC.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. ATCC
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. GENERAL ELECTRIC COMPANY
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies
1. VitaCyte, LLC.
2. BD
3. Thermo Fisher Scientific Inc.
4. PAN-Biotech
5. Merck KGaA
6. HiMedia Laboratories
7. Miltenyi Biotec GmbH
8. STEMCELL Technologies Inc.
9. General Electric Company
10. ATCC
11. Corning Inc.
12. Accegen
13. Cellsystems Gmbh
14. Innovative Cell Technologies, Inc.
15. American Type Culture Collection
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For